JAMES M. GOWER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

RIGEL PHARMACEUTICALS INC

Filing Date Source Excerpt
2006-04-25 James M. Gower, age 57, has been our Chairman of the Board and Chief Executive Officer since October 2001. Mr. Gower joined us as our President, Chief Executive Officer and as a member of our Board of Directors in January 1997. ... Mr. Gower serves on the board of directors of Cell Genesys, Inc. He holds a B.S. and an M.B.A. in operations research from the University of Tennessee.
2007-03-26 James M. Gower, age 58, has been our Chairman of the Board and Chief Executive Officer since October 2001. Mr. Gower joined us as our President, Chief Executive Officer and as a member of our Board of Directors in January 1997. ... The Board consults with our counsel to ensure that the Board's determinations are consistent with relevant securities and other laws and regulations regarding the definition of "independent," including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time. ... Consistent with these considerations, after review of all relevant transactions or relationships between each director, or any of his family members, and Rigel, our senior management and our independent auditors, the Board has affirmatively that all of our current directors are independent directors within the meaning of the applicable Nasdaq listing standards, except for James M. Gower, our Chairman of the Board of Directors and Chief Executive Officer, and Donald G. Payan, our Executive Vice President and Chief Scientific Officer who are not independent directors by virtue of their employment with the Company.
2008-04-08 James M. Gower, age 59, has been our Chairman of the Board and Chief Executive Officer since October 2001. ... The Finance Committee comprised two directors during fiscal 2007: Mr. Gower and Dr. Deleage. ... The Board has four standing committees: an Audit Committee, a Compensation Committee, a Finance Committee and a Nominating and Corporate Governance Committee.
2009-04-15 James M. Gower, age 60, joined us as our President, Chief Executive Officer and as a member of our Board in January 1997, and has been our Chairman of the Board since October 2001. ... The following three directors are the members of the Finance Committee: Mr. Gower and Drs. Deleage and Sherwin, each of whom were on the Finance Committee for all of fiscal year 2008. ... For services provided in 2008, each non-employee director of Rigel received a yearly retainer of $30,000, ... In the fiscal year ended December 31, 2008, the total cash compensation earned by non-employee directors was $373,000.
2011-04-04 James M. Gower, age 62, joined us as our President, Chief Executive Officer and as a member of our Board in January 1997, and has been our Chairman of the Board and Chief Executive Officer since October 2001. The Board concluded that Mr. Gower continues to be a valuable member of the Board in part due to his role as our President and Chief Executive Officer and his knowledge of the day-to-day operations of Rigel obtained as a result of that role.
2012-04-12 James M. Gower, age 63, joined us as our President, Chief Executive Officer and as a member of our Board in January 1997, and has been our Chairman of the Board and Chief Executive Officer since October 2001. ... The Board has four standing committees: ... Finance Committee ... The following three directors are the members of the Finance Committee: Messrs. Gower and Lyons and Dr. Sherwin. ... For services provided in 2011, each non-employee director of Rigel received a yearly retainer of $30,000, ... In the fiscal year ended December 31, 2011, the total cash compensation earned by non-employee directors was $375,750. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2011: ... James M. Gower ... Total $1,443,338.
2014-04-08 James M. Gower, age 65, joined us as our President, Chief Executive Officer and as a member of our Board in January 1997, and has been our Chairman of the Board and Chief Executive Officer since October 2001. ... The Board concluded that Mr. Gower should continue to serve as a member of the Board in part due to his role as our Chief Executive Officer and his knowledge of the day-to-day operations of Rigel obtained as a result of that role. ... The following three directors are the members of the Finance Committee: Messrs. Gower and Lyons and Dr. Sherwin, all of whom were on the Finance Committee for all of fiscal year 2013.

Data sourced from SEC filings. Last updated: 2026-03-05